2. INTRODUCTION
• Immunodeficiency is an abnormal condition of the immune
system in which cellular or humoral immunity is inadequate
and resistance to infection is decreased.
• First evidence of immunodeficiency is an increased
susceptibility to infection.
3. • Immunodeficiency disorders involve an impairment of one
or more of the following immune mechanisms:
• Phagocytosis
• Humoral response
• Cell-mediated response
• Complement
• Combined humoral and cell-mediated deficiency
5. FACTORS AFFECTING IMMUNE
SYSTEM
Central nervous
system integrity
General physical
and emotional
status
Medications Dietary patterns
Stress of illness Trauma or
Surgery
7. Primary immunodeficiency disorders
Primary immunodeficiency disorders are inborn
errors of immune function that predispose people to
frequent, severe infections; autoimmunity; and cancer.
8. Primary immunodeficiency
disorders
• The majority of primary immunodeficiencies are diagnosed in
infancy, with a male-to-female ratio of 5 to 1.
• To date, more than 120 immunodeficiencies of genetic origin
have bee identified.
• Common primary immunodeficiencies include
• Disorders of humoral immunity (affecting b-cell differentiation or
antibody production),
• T-cell defects,
• Combined b- and t-cell defects,
• Phagocytic disorders, and
• Complement deficiencies
9. Phagocytic cells
• Disorder
• Hyperimmunoglobulinemia E (HIE) syndrome
• Major Symptoms
• Bacterial, fungal, and viral infections; deep-seated cold
abscesses
• Treatment
• Antibiotic therapy and treatment for viral and fungal infections
• Granulocyte-macrophage colony stimulating factor (GM-CSF);
granulocyte colony-stimulating factor (G-CSF)
10. B lymphocyte
• Disorder
• Sex-linked
agammaglobulinemia
(Bruton’s disease)
• Major Symptoms
• Severe pyogenic infections
soon after birth
• Treatment
• Passive pooled plasma or
gamma globulin
18. B and T lymphocytes
• Disorder
• Ataxia-telangiectasia
• Major symptoms
• Ataxia with progressive neurologic deterioration, telangiectasia
(vascular lesions), recurrent infections; malignancies
• Treatment
• Antimicrobial therapy;
• management of presenting symptoms;
• fetal thymus transplant,
• IVIG
19. B and T lymphocytes
• Disorder
• Nezelof ’s syndrome (under development of thymus)
• Major symptoms
• Severe infections, malignancies
• Treatment
• Antimicrobial therapy;
• IVIG,
• Bone marrow transplantation;
• Thymus transplantation;
• Thymus factors
20. B and T lymphocytes
• Disorder
• Wiskott-aldrich syndrome
• Major symptoms
• Thrombocytopenia, resulting in bleeding, infections;
malignancies
• Treatment
• Antimicrobial therapy;
• Splenectomy with continuous antibiotic prophylaxis;
• IVIG and
• Bone marrow transplantation
21.
22. B and T lymphocytes
• Disorder
• Severe combined immunodeficiency disease (SCID)
• Major symptoms
• Overwhelming severe fatal infections soon after birth (also
includes opportunistic infections
• Treatment
• Antimicrobial therapy;
• IVIG and
• bone marrow transplantation
23. Complement system
• Disorder
• Angioneurotic edema
• Major symptoms
• Episodes of edema in various parts of the body, including
respiratory tract and bowels
• Treatment
• Pooled plasma, androgen therapy
24. Complement system
• Disorder
• Paroxysmal nocturnal hemoglobinuria (PNH)
• Major symptoms
• Lysis of erythrocytes due to lack of decay-accelerating factor
(DAF) on erythrocytes
• Treatment
• None
25. • Primary immune deficiency causes children and adults to
have infections that come back frequently or are
unusually hard to cure.
• In America alone, up to half a million people suffer from
one or more of the 70 known primary immune deficiency
diseases.
28. Secondary immunodeficiencies
• Secondary immunodeficiencies are more common than
primary immunodeficiencies
• Frequently occur as a result of underlying disease
processes or the treatment of these disorders.
29. Factors
• Intrinsic factors, including
• Immunosuppressive agents,
• Harsh environmental conditions,
• Hereditary disorders other than
primary immunodeficiencies,
and
• Acquired metabolic disorders
that cause secondary
immunodeficiencies
30. Causes Chronic stress
Burns
Uraemia
Diabetes mellitus
Certain autoimmune disorders
Certain viruses
Exposure to immunotoxic medications and chemicals
Self-administration of recreational drugs and alcohol.
32. Medical Management
• Diagnosis and treatment of the underlying disease
process.
• Treatment of the primary condition often results in the
improvement of the affected immune components
• Factors that contribute to immunosuppression are
identified and infection is treated.
• Additional treatment includes HSCT, monoclonal
antibody therapy, and anticoagulation therapy as
indicated.